Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.

Bile acid signaling is a critical regulator of glucose and energy metabolism, mainly through the nuclear receptor FXR and the G protein-coupled receptor TGR. The purpose of the present study was to investigate whether dual activation of FXR and TGR5 plays a significant role in the prevention of athe...

Full description

Bibliographic Details
Main Authors: Shinobu Miyazaki-Anzai, Masashi Masuda, Moshe Levi, Audrey L Keenan, Makoto Miyazaki
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4169583?pdf=render
_version_ 1828844927957598208
author Shinobu Miyazaki-Anzai
Masashi Masuda
Moshe Levi
Audrey L Keenan
Makoto Miyazaki
author_facet Shinobu Miyazaki-Anzai
Masashi Masuda
Moshe Levi
Audrey L Keenan
Makoto Miyazaki
author_sort Shinobu Miyazaki-Anzai
collection DOAJ
description Bile acid signaling is a critical regulator of glucose and energy metabolism, mainly through the nuclear receptor FXR and the G protein-coupled receptor TGR. The purpose of the present study was to investigate whether dual activation of FXR and TGR5 plays a significant role in the prevention of atherosclerosis progression. To evaluate the effects of bile acid signaling in atherogenesis, ApoE-/- mice and LDLR-/- mice were treated with an FXR/TGR5 dual agonist (INT-767). INT-767 treatment drastically reduced serum cholesterol levels. INT-767 treatment significantly reduced atherosclerotic plaque formation in both ApoE-/- and LDLR-/- mice. INT-767 decreased the expression of pro-inflammatory cytokines and chemokines in the aortas of ApoE-/- mice through the inactivation of NF-κB. In addition, J774 macrophages treated with INT-767 had significantly lower levels of active NF-κB, resulting in cytokine production in response to LPS through a PKA dependent mechanism. This study demonstrates that concurrent activation of FXR and TGR5 attenuates atherosclerosis by reducing both circulating lipids and inflammation.
first_indexed 2024-12-12T21:16:58Z
format Article
id doaj.art-d43d715e43174d15bfdc8aaca7d849f2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T21:16:58Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d43d715e43174d15bfdc8aaca7d849f22022-12-22T00:11:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10827010.1371/journal.pone.0108270Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.Shinobu Miyazaki-AnzaiMasashi MasudaMoshe LeviAudrey L KeenanMakoto MiyazakiBile acid signaling is a critical regulator of glucose and energy metabolism, mainly through the nuclear receptor FXR and the G protein-coupled receptor TGR. The purpose of the present study was to investigate whether dual activation of FXR and TGR5 plays a significant role in the prevention of atherosclerosis progression. To evaluate the effects of bile acid signaling in atherogenesis, ApoE-/- mice and LDLR-/- mice were treated with an FXR/TGR5 dual agonist (INT-767). INT-767 treatment drastically reduced serum cholesterol levels. INT-767 treatment significantly reduced atherosclerotic plaque formation in both ApoE-/- and LDLR-/- mice. INT-767 decreased the expression of pro-inflammatory cytokines and chemokines in the aortas of ApoE-/- mice through the inactivation of NF-κB. In addition, J774 macrophages treated with INT-767 had significantly lower levels of active NF-κB, resulting in cytokine production in response to LPS through a PKA dependent mechanism. This study demonstrates that concurrent activation of FXR and TGR5 attenuates atherosclerosis by reducing both circulating lipids and inflammation.http://europepmc.org/articles/PMC4169583?pdf=render
spellingShingle Shinobu Miyazaki-Anzai
Masashi Masuda
Moshe Levi
Audrey L Keenan
Makoto Miyazaki
Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
PLoS ONE
title Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
title_full Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
title_fullStr Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
title_full_unstemmed Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
title_short Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
title_sort dual activation of the bile acid nuclear receptor fxr and g protein coupled receptor tgr5 protects mice against atherosclerosis
url http://europepmc.org/articles/PMC4169583?pdf=render
work_keys_str_mv AT shinobumiyazakianzai dualactivationofthebileacidnuclearreceptorfxrandgproteincoupledreceptortgr5protectsmiceagainstatherosclerosis
AT masashimasuda dualactivationofthebileacidnuclearreceptorfxrandgproteincoupledreceptortgr5protectsmiceagainstatherosclerosis
AT moshelevi dualactivationofthebileacidnuclearreceptorfxrandgproteincoupledreceptortgr5protectsmiceagainstatherosclerosis
AT audreylkeenan dualactivationofthebileacidnuclearreceptorfxrandgproteincoupledreceptortgr5protectsmiceagainstatherosclerosis
AT makotomiyazaki dualactivationofthebileacidnuclearreceptorfxrandgproteincoupledreceptortgr5protectsmiceagainstatherosclerosis